HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo - PubMed (original) (raw)
. 2005 Feb 15;105(4):1456-66.
doi: 10.1182/blood-2004-04-1583. Epub 2004 Nov 2.
Affiliations
- PMID: 15522959
- DOI: 10.1182/blood-2004-04-1583
Free article
HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo
Neal A Fischbach et al. Blood. 2005.
Free article
Abstract
The HOX family of homeobox genes plays an important role in normal and malignant hematopoiesis. Dysregulated HOX gene expression profoundly effects the proliferation and differentiation of hematopoietic stem cells (HSCs) and committed progenitors, and aberrant activation of HOX genes is a common event in human myeloid leukemia. HOXB6 is frequently overexpressed in human acute myeloid leukemia (AML). To gain further insight into the role of HOXB6 in hematopoiesis, we overexpressed HOXB6 in murine bone marrow using retrovirus-mediated gene transfer. We also explored structure-function relationships using mutant HOXB6 proteins unable to bind to DNA or a key HOX-binding partner, pre-B-cell leukemia transcription factor-1 (PBX1). Additionally, we investigated the potential cooperative interaction with myeloid ecotropic viral integration site 1 homolog (MEIS1). In vivo, HOXB6 expanded HSCs and myeloid precursors while inhibiting erythropoiesis and lymphopoiesis. Overexpression of HOXB6 resulted in AML with a median latency of 223 days. Coexpression of MEIS1 dramatically shortened the onset of AML. Cytogenetic analysis of a subset of HOXB6-induced AMLs revealed recurrent deletions of chromosome bands 2D-E4, a region frequently deleted in HOXA9-induced AMLs. In vitro, HOXB6 immortalized a factor-dependent myelomonocytic precursor capable of granulocytic and monocytic differentiation. These biologic effects of HOXB6 were largely dependent on DNA binding but independent of direct interaction with PBX1.
Similar articles
- Meis1 programs transcription of FLT3 and cancer stem cell character, using a mechanism that requires interaction with Pbx and a novel function of the Meis1 C-terminus.
Wang GG, Pasillas MP, Kamps MP. Wang GG, et al. Blood. 2005 Jul 1;106(1):254-64. doi: 10.1182/blood-2004-12-4664. Epub 2005 Mar 8. Blood. 2005. PMID: 15755900 Free PMC article. - The role of Hox proteins in leukemogenesis: insights into key regulatory events in hematopoiesis.
Eklund E. Eklund E. Crit Rev Oncog. 2011;16(1-2):65-76. doi: 10.1615/critrevoncog.v16.i1-2.70. Crit Rev Oncog. 2011. PMID: 22150308 Free PMC article. Review. - HOX gene regulation in acute myeloid leukemia: CDX marks the spot?
Fröhling S, Scholl C, Bansal D, Huntly BJ. Fröhling S, et al. Cell Cycle. 2007 Sep 15;6(18):2241-5. doi: 10.4161/cc.6.18.4656. Epub 2007 Jun 29. Cell Cycle. 2007. PMID: 17881901 Review.
Cited by
- Comprehensive summary: the role of PBX1 in development and cancers.
Liu M, Xing Y, Tan J, Chen X, Xue Y, Qu L, Ma J, Jin X. Liu M, et al. Front Cell Dev Biol. 2024 Jul 26;12:1442052. doi: 10.3389/fcell.2024.1442052. eCollection 2024. Front Cell Dev Biol. 2024. PMID: 39129784 Free PMC article. Review. - Sequential gene expression analysis of myelodysplastic syndrome transformation identifies HOXB3 and HOXB7 as the novel targets for mesenchymal cells in disease.
Yin C, Li Y, Zhang C, Zang S, Wang Z, Yan X, Ma T, Li X, Li W. Yin C, et al. BMC Cancer. 2024 Jan 22;24(1):111. doi: 10.1186/s12885-024-11859-w. BMC Cancer. 2024. PMID: 38254070 Free PMC article. - Clinical implication and potential function of ARHGEF6 in acute myeloid leukemia: An in vitro study.
Li K, Wang H, Yang C, Li C, Xue B, Zhou J. Li K, et al. PLoS One. 2023 Apr 7;18(4):e0283934. doi: 10.1371/journal.pone.0283934. eCollection 2023. PLoS One. 2023. PMID: 37027440 Free PMC article. - Disruption of the Gut Microbiota Confers Cisplatin Resistance in Epithelial Ovarian Cancer.
Chambers LM, Esakov Rhoades EL, Bharti R, Braley C, Tewari S, Trestan L, Alali Z, Bayik D, Lathia JD, Sangwan N, Bazeley P, Joehlin-Price AS, Wang Z, Dutta S, Dwidar M, Hajjar A, Ahern PP, Claesen J, Rose P, Vargas R, Brown JM, Michener CM, Reizes O. Chambers LM, et al. Cancer Res. 2022 Dec 16;82(24):4654-4669. doi: 10.1158/0008-5472.CAN-22-0455. Cancer Res. 2022. PMID: 36206317 Free PMC article. - Single-cell analysis of transcription factor regulatory networks reveals molecular basis for subtype-specific dysregulation in acute myeloid leukemia.
Sun R, Sun L, Xie X, Li X, Wu P, Wang L, Zhu P. Sun R, et al. Blood Sci. 2022 May 17;4(2):65-75. doi: 10.1097/BS9.0000000000000113. eCollection 2022 Apr. Blood Sci. 2022. PMID: 35957668 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials